Skip to main content

SIG | Pediatric Epilepsy Case Discussions: Diagnostic and Treatment Challenges

Sunday, December 5, 2021
-

You may need to log in to view video on this page.

OVERVIEW:

This session highlights the importance of precision medicine and treatments for pediatric epilepsy.  

This Special Interest Group has provided an engaging platform to share complex challenges in the management of pediatric epilepsy for more than two decades.  Early-career and seasoned epileptologists from both academic and private centers worldwide have the opportunity to explore and interact around illustrative clinical experience.  

This year, the Pediatric Epilepsy Case Discussions SIG highlights cases demonstrating the importance of precision medicine and treatment options for epilepsy due to genetic etiologies. 

Learning Objectives:

Following participation in this activity, participants will be able to: 

  • Clarify the importance of using precision medicine to identify the preferred treatment options for epilepsy due to genetic etiologies 
  • Recognize the variable expressivity of autosomal dominant genetic disorders and how this affects treatments and outcomes 
  • Identify patients with epilepsy due to genetic etiology who may benefit from epilepsy surgery 

Program:

SIG Coordinators: Katherine Nichols, MD, Ajay Gupta, MD, FAES, and Sarah Kelley, MD 

Chair: Katherine Nichols, MD 

Co-Chair: Ajay Gupta, MD, FAES 

Precision Medicine for mTOR-opathies | Anthony Fine, MD 

Ketogenic Diet as Precision Therapy for Metabolic Disorders | Sarah Kelley, MD 

Same Genetics/Different Syndromes: Addressing Variable Expressivity in Genetic Epilepsies |  Nilika Singhal, MD 

Surgery as Precision Treatment for Genetic Epilepsies | Ajay Gupta, MD, FAES 
 

Education Credit:

1.5 Nursing Contact Hours 

1.5 Pharmacy Contact Hours

1.5 CME 

This educational activity is supported in part by an education grant from: LivaNova 

Activity Type
Special Interest Group
Credit
CME
CE
Format
In person
On-demand
Career Stage
Early Career (typically 0-5 years from completion of training)
Mid-Career (typically 6-15 years from completion of training)
Senior (typically >15 years from completion of training)
Audience
Advocates
Advanced Practice Providers
Behavioral Health Providers
Clinicians
Fellows/Trainees
Nurses
Pharmacists
Scientists/Researchers
Technicians
Demographic
Clinical
First-time Attendees
Research